Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

11

Revenue 2017

AstraZeneca

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AstraZeneca's 2013 sales performance.

Astra Zeneca

New study identifies gene associated with strong immune response to COVID-19 vaccines

New study identifies gene associated with strong immune response to COVID-19 vaccines They also looked at DNA samples from children who had participated in clinical trials for the Oxford-AstraZeneca vaccine.

UK Government announces £800m boost to support innovation and improve patient safety

UK Government announces £800m boost to support innovation and improve patient safety The NIHR BRCs have supported almost 60, 000 experimental medicine research studies over the past nine years including the development of the Oxford AstraZeneca COVID-19 vaccine, as well as promising

AstraZeneca’s Tezspire receives MHRA approval as add-on treatment for severe asthma

AstraZeneca’s Tezspire receives MHRA approval as add-on treatment for severe asthma Tezspire demonstrated reduced annualised rate of asthma exacerbations. AstraZeneca’s (AZ) Tezspire (tezepelumab) has been granted marketing authorisation in Great Britain by the Medicines and Healthcare products Regulatory Agency (MHRA) for

EC approves Alexion's Ultomiris as generalised myasthenia gravis treatment

EC approves Alexion's Ultomiris as generalised myasthenia gravis treatment The European Commission (EC) has approved Aexion’s – part of the AstraZeneca Rare Disease group – Ultomiris (ravulizumab) in Europe as an add-on to standard therapy for generalised myasthenia gravis (gMG).

AstraZeneca’s Tezspire receives EC approval as severe asthma add-on treatment

AstraZeneca’s Tezspire receives EC approval as severe asthma add-on treatment AstraZeneca’s (AZ) Tezspire (tezepelumab) has been approved by the European Commission (EC) for use as an add-on maintenance treatment in patients 12 years and older with severe asthma, the

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
nzyme

The nzyme group focuses on the three fundamentals that enable full patient access - Education, Access & Activation. Our specialist...

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...